Bal Pharma Ltd has informed BSE that the meeting of Board of Directors of the Company is scheduled to be held on February 07, 2017, inter alia, to take on record and approve the Un-Audited financial results of the Company for the quarter ended December 31, 2016.<BR><BR>Further, pursuant to Prohibition of Insider Trading Regulations, 2015 of SEBI and as per the provisions of Code of Conduct of the Company, the trading window on the designated employees of the Company and their immediate relatives shall remain closed from January 25, 2017 up to February 08, 2017.
|